
GMAB Market Capitalization Overview
Market Cap: $15.60B as of Apr 29, 2026
$15.60B
$317.36M (1.99%)past month
As of Apr 29, 2026, GMAB has a market capitalization of $15.60B. Over the past 30 days, its market cap has decreased by -8.18%, while in the last 12 months, it has decreased by -17.8%.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMABhelps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMABhelps investors assess the company's size and compare it with competitors for better investment decisions.
GMAB Market Cap & Key Trends
See Genmab - ADR’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in GMAB
Order type
Buy in
Order amount
Est. shares
0 shares
GMAB Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Apr 1, 2026 | $16.78B | -8.18% |
| Mar 2, 2026 | $18.28B | -10.85% |
| Feb 2, 2026 | $20.50B | +4.56% |
| Jan 2, 2026 | $19.61B | +1.37% |
GMAB End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $15.60B | -17.80% |
| 2025 | $18.98B | +43.11% |
| 2024 | $13.26B | -36.26% |
| 2023 | $20.80B | -24.92% |
| 2022 | $27.71B | +7.03% |
| 2021 | $25.89B | — |
FAQs About Genmab - ADR (GMAB) Market Cap
As of Apr 29, 2026, the market capitalization of GMAB is $15.60B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Genmab - ADR’s market capitalization has decreased by -1.99%, changing from $15.92B to $15.60B as of Apr 29, 2026.
In the last 3 months, Genmab - ADR’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Genmab - ADR’s market capitalization increased from $13.26B in January to $18.98B in December, reflecting a 43.11% change.
In the past five years, GMAB has had a compound annual growth rate (CAGR) of -6.02% in market capitalization. This means its market cap has shrunk at an average rate of -6.02% per year.